Roche Scoops Up Verum Diagnostica

Law360, New York (December 5, 2011, 2:35 PM EST) -- Swiss pharmaceutical and diagnostics giant F. Hoffmann-La Roche Ltd. will acquire Verum Diagnostica GmbH for at least $14.8 million to help grow its blood clotting testing business, Roche announced Monday.

Roche will pay shareholders of the German company — a wholly owned subsidiary of Dynabyte Informationssysteme GmbH — $14.8 million and potentially $2.7 million more based on certain performance-related milestones, according to the company. The deal is expected to close in January.

Munich-based Verum Diagnostica makes the Multiplate analyzer for testing the functioning of blood platelets,...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.